Pre-administration of turmeric prevents methotrexate-induced liver toxicity and oxidative stress

BMC Complementary and Alternative Medicine

Volumn 15, Issue 1, 2015, Pages

  Moghadam, Adel Rezaei ^a   Tutunchi, Soheil ^a   Namvaran Abbas Abad, Ali ^a   Yazdi, Mina ^b   Bonyadi, Fatemeh ^c   Mohajeri, Daryoush ^a   Mazani, Mohammad ^d   Marzban, Hassan ^e   Łos, Marek J ^f,g,h   Ghavami, Saeid ^e,i  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b UNIVERSITY OF TEHRAN   (Iran)

^c ISLAMIC AZAD UNIVERSITY   (Iran)

^d ARDABIL UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e UNIVERSITY OF MANITOBA   (Canada)

^f LINKÖPING UNIVERSITY   (Sweden)

^g POMERANIAN MEDICAL UNIVERSITY   (Poland)

^h MEDICAL UNIVERSITY OF SILESIA   (Poland)

ⁱ SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antioxidant enzymes; Cell death; Hepatocellular injury; Lipid peroxides; Serum liver biomarkers; Total antioxidant status

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CATALASE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; METHOTREXATE; SUPEROXIDE DISMUTASE; TURMERIC; PLANT EXTRACT; PROTECTIVE AGENT; TURMERIC EXTRACT;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CELL DEATH; CELL INFILTRATION; CENTRILOBULAR DEGENERATION; CONTROLLED STUDY; CURCUMA LONGA; DEGENERATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG ISOLATION; ENZYME ACTIVITY; HYPEREMIA; IN VIVO STUDY; INFLAMMATORY CELL; LIPID PEROXIDATION; LIVER DISEASE; LIVER INJURY; LIVER PROTECTION; LIVER TOXICITY; LIVER WEIGHT; MALE; NONHUMAN; OXIDATIVE STRESS; PERIPORTAL DEGENERATION; RAT; ANIMAL; CHEMICAL AND DRUG INDUCED LIVER INJURY; CURCUMA; DRUG EFFECTS; LIVER; METABOLISM; PATHOLOGY; WISTAR RAT;

ANIMALS; CHEMICAL AND DRUG INDUCED LIVER INJURY; CURCUMA; LIVER; MALE; METHOTREXATE; OXIDATIVE STRESS; PLANT EXTRACTS; PROTECTIVE AGENTS; RATS; RATS, WISTAR;

EID: 84937710356     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/s12906-015-0773-6     Document Type: Article

References (89)

1. Sakthiswary R, Suresh E. Methotrexate in systemic lupus erythematosus: a systematic review of its efficacy. Lupus. 2014;23:225-35. 0961203313519159.
2. Zhu H, Deng F-Y, Mo X-B, Qiu Y-H, Lei S-F. Pharmacogenetics and pharmacogenomics for rheumatoid arthritis responsiveness to methotrexate treatment: the 2013 update. Pharmacogenomics. 2014;15(4):551-66.
3. Maybury CM, Jabbar-Lopez ZK, Wong T, Dhillon AP, Barker JN, Smith CH. Methotrexate and liver fibrosis in people with psoriasis: a systematic review of observational studies. Br J Dermatol. 2014;171(1):17-29.
4. Ayad MW, El Naggar AA, El Naggar M. MTHFR C677T polymorphism: association with lymphoid neoplasm and effect on methotrexate therapy. Eur J Haematol. 2014;93(1):63-9.
5. Triantafyllou K, Vlachogiannakos J, Ladas SD. Gastrointestinal and liver side effects of drugs in elderly patients. Best Pract Res Clin Gastroenterol. 2010;24(2):203-15.
6. Duman DG, Kumral ZNÖ, Ercan F, Deniz M, Can G, Çağlayan Yeğen B. Saccharomyces boulardii ameliorates clarithromycin-and methotrexate-induced intestinal and hepatic injury in rats. Br J Nutr. 2013;110(03):493-9.
7. Ali N, Rashid S, Nafees S, Hasan SK, Sultana S. Beneficial effects of Chrysin against Methotrexate-induced hepatotoxicity via attenuation of oxidative stress and apoptosis. Mol Cell Biochem. 2014;385(1-2):215-23.
8. Messarah M, Boumendjel A, Chouabia A, Klibet F, Abdennour C, Boulakoud MS, et al. Influence of thyroid dysfunction on liver lipid peroxidation and antioxidant status in experimental rats. Exp Toxicol Pathol. 2010;62(3):301-10.
9. Richter C, Gogvadze V, Laffranchi R, Schlapbach R, Schweizer M, Suter M, et al. Oxidants in mitochondria: from physiology to diseases. Biochim Biophys Acta. 1995;1271(1):67-74.
10. Nickel A, Kohlhaas M, Maack C. Mitochondrial reactive oxygen species production and elimination. J Mol Cell Cardiol. 2014;73:26-33.
11. Tabassum H, Parvez S, Pasha ST, Banerjee BD, Raisuddin S. Protective effect of lipoic acid against methotrexate-induced oxidative stress in liver mitochondria. Food Chem Toxicol. 2010;48(7):1973-9.
12. Kolli V, Natarajan K, Isaac B, Selvakumar D, Abraham P. Mitochondrial dysfunction and respiratory chain defects in a rodent model of methotrexate-induced enteritis. Hum Exp Toxicol. 2013;33(10):1051-65. 0960327113515503.
13. Hemeida RA, Mohafez OM. Curcumin attenuates methotraxate-induced hepatic oxidative damage in rats. J Egypt Natl Canc Inst. 2008;20(2):141-8.
14. Bartsch H, Nair J. Ultrasensitive and specific detection methods for exocylic DNA adducts: markers for lipid peroxidation and oxidative stress. Toxicology. 2000;153(1):105-14.
15. Stohs S, Bagchi D. Oxidative mechanisms in the toxicity of metal ions. Free Radic Biol Med. 1995;18(2):321-36.
16. Padma VV, Baskaran R, Roopesh RS, Poornima P. Quercetin attenuates lindane induced oxidative stress in wistar rats. Mol Biol Rep. 2012;39(6):6895-905.
17. Uz E, Söğüt S, Şahin Ş, Var A, Özyurt H, Güleç M, et al. The protective role of caffeic acid phenethyl ester (CAPE) on testicular tissue after testicular torsion and detorsion. World J Urol. 2002;20(4):264-70.
18. Uzar E, Koyuncuoglu HR, Uz E, Yilmaz HR, Kutluhan S, Kilbas S, et al. The activities of antioxidant enzymes and the level of malondialdehyde in cerebellum of rats subjected to methotrexate: protective effect of caffeic acid phenethyl ester. Mol Cell Biochem. 2006;291(1-2):63-8.
19. Lai CS, Wu JC, Yu SF, Badmaev V, Nagabhushanam K, Ho CT, et al. Tetrahydrocurcumin is more effective than curcumin in preventing azoxymethane-induced colon carcinogenesis. Mol Nutr Food Res. 2011;55(12):1819-28.
20. Kuttan R, Bhanumathy P, Nirmala K, George M. Potential anticancer activity of turmeric (< i > Curcuma longa). Cancer Lett. 1985;29(2):197-202.
21. Chattopadhyay I, Biswas K, Bandyopadhyay U, Banerjee RK. Turmeric and curcumin: Biological actions and medicinal applications. Curr Sci. 2004;87(1):44-53.
22. Mishra S, Palanivelu K. The effect of curcumin (turmeric) on Alzheimer's disease: An overview. Ann Indian Acad Neurol. 2008;11(1):13.
23. Li S, Yuan W, Deng G, Wang P, Yang P, Aggarwal BB. Chemical composition and product quality control of turmeric (Curcuma longa L.). Pharmaceutical Crops. 2011;2:28-54.
24. Gupta SC, Sung B, Kim JH, Prasad S, Li S, Aggarwal BB. Multitargeting by turmeric, the golden spice: from kitchen to clinic. Mol Nutr Food Res. 2013;57(9):1510-28.
25. Reddy ACP, Lokesh B. Effect of dietary turmeric (Curcuma longa) on iron-induced lipid peroxidation in the rat liver. Food Chem Toxicol. 1994;32(3):279-83.
26. Selvam R, Subramanian L, Gayathri R, Angayarkanni N. The anti-oxidant activity of turmeric (Curcuma longa). J Ethnopharmacol. 1995;47(2):59-67.
27. Gupta SC, Kismali G, Aggarwal BB. Curcumin, a component of turmeric: from farm to pharmacy. Biofactors. 2013;39(1):2-13.
28. Katiyar SK, Agarwal R, Mukhtar H. Inhibition of tumor promotion in SENCAR mouse skin by ethanol extract of Zingiber officinale rhizome. Cancer Res. 1996;56(5):1023-30.
29. Pari L, Murugan P. Protective role of tetrahydrocurcumin against erythromycin estolate-induced hepatotoxicity. Pharmacol Res. 2004;49(5):481-6.
30. Woreta TA, Alqahtani SA. Evaluation of abnormal liver tests. Med Clin North Am. 2014;98(1):1-16.
31. Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem. 2004;37(2):112-9.
32. Paoletti F, Aldinucci D, Mocali A, Caparrini A. A sensitive spectrophotometric method for the determination of superoxide dismutase activity in tissue extracts. Anal Biochem. 1986;154(2):536-41.
33. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med. 1967;70(1):158-69.
34. Claiborne A. Handbook of methods for oxygen radical research. Florida: CRC Press, Boca Raton; 1985.
35. Esterbauer H, Cheeseman K. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol. 1990;186:407-21.
36. Jamshidzadeh A, Baghban M, Azarpira N, Bardbori AM, Niknahad H. Effects of tomato extract on oxidative stress induced toxicity in different organs of rats. Food Chem Toxicol. 2008;46(12):3612-5.
37. Tian H, Cronstein BN. Understanding the mechanisms of action of methotrexate. ull NYU Hosp Jt Dis. 2007;65(3):168-73.
38. van Swelm RP, Laarakkers CM, Kooijmans-Otero M, de Jong EM, Masereeuw R, Russel FG. Biomarkers for methotrexate-induced liver injury: Urinary protein profiling of psoriasis patients. Toxicol Lett. 2013;221(3):219-24.
39. Tian H, Cronstein BN. Understanding the mechanisms of action of methotrexate: implications for the treatment of rheumatoid arthritis. Bull NYU Hosp Jt Dis. 2007;65(3):168-73.
40. Berkun Y, Levartovsky D, Rubinow A, Orbach H, Aamar S, Grenader T, et al. Methotrexate related adverse effects in patients with rheumatoid arthritis are associated with the A1298C polymorphism of the MTHFR gene. Ann Rheum Dis. 2004;63(10):1227-31.
41. Sitzia J, Huggins L. Side effects of cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) chemotherapy for breast cancer. Cancer Pract. 1998;6(1):13-21.
42. Tsai W-H, Yang C-C, Li P-C, Chen W-C, Chien C-T. Therapeutic Potential of Traditional Chinese Medicine on Inflammatory Diseases. J Tradit Complement Med. 2013;3(3):142.
43. Wang H, Guan W, Yang W, Wang Q, Zhao H, Yang F, et al. Caffeine Inhibits the Activation of Hepatic Stellate Cells Induced by Acetaldehyde via Adenosine A2A Receptor Mediated by the cAMP/PKA/SRC/ERK1/2/P38 MAPK Signal Pathway. PLoS One. 2014;9(3):e92482.
44. Chan ES, Cronstein BN. Methotrexate-how does it really work? Nat Rev Rheumatol. 2010;6(3):175-8.
45. Arafa HM. Curcumin attenuates diet-induced hypercholesterolemia in rats. Med Sci Monit. 2005;11(7):BR228-234.
46. Epstein J, Sanderson IR, MacDonald TT. Curcumin as a therapeutic agent: the evidence from in vitro, animal and human studies. Br J Nutr. 2010;103(11):1545-57.
47. Shehzad A, Lee YS. Molecular mechanisms of curcumin action: signal transduction. Biofactors. 2013;39(1):27-36.
48. Wongcharoen W, Phrommintikul A. The protective role of curcumin in cardiovascular diseases. Int J Cardiol. 2009;133(2):145-51.
49. Weisberg SP, Leibel R, Tortoriello DV. Dietary curcumin significantly improves obesity-associated inflammation and diabetes in mouse models of diabesity. Endocrinology. 2008;149(7):3549-58.
50. Kunnumakkara AB, Anand P, Aggarwal BB. Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett. 2008;269(2):199-225.
51. Lin J-K. Molecular targets of curcumin. In: The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease. Springer; 2007. p. 227-43. ISBN 978-0-387-46401-5.
52. Gupta SC, Prasad S, Kim JH, Patchva S, Webb LJ, Priyadarsini IK, et al. Multitargeting by curcumin as revealed by molecular interaction studies. Nat Prod Rep. 2011;28(12):1937-55.
53. Suryanarayana P, Saraswat M, Mrudula T, Krishna TP, Krishnaswamy K, Reddy GB. Curcumin and turmeric delay streptozotocin-induced diabetic cataract in rats. Invest Ophthalmol Vis Sci. 2005;46(6):2092-9.
54. 1) Cell Injury. Free Radic Biol Med. 1998;24(1):49-54.
55. Nishiyama T, Mae T, Kishida H, Tsukagawa M, Mimaki Y, Kuroda M, et al. Curcuminoids and sesquiterpenoids in turmeric (Curcuma longa L.) suppress an increase in blood glucose level in type 2 diabetic KK-Ay mice. J Agric Food Chem. 2005;53(4):959-63.
56. Finkel T. Oxidant signals and oxidative stress. Curr Opin Cell Biol. 2003;15(2):247-54.
57. Ghavami S, Shojaei S, Yeganeh B, Ande SR, Jangamreddy JR, Mehrpour M, et al. Autophagy and apoptosis dysfunction in neurodegenerative disorders. Prog Neurobiol. 2014;112:24-49.
58. Ott M, Gogvadze V, Orrenius S, Zhivotovsky B. Mitochondria, oxidative stress and cell death. Apoptosis. 2007;12(5):913-22.
59. Yeganeh B, Moghadam AR, Tran AT, Rahim MN, Ande SR, Hashemi M, et al. Asthma and influenza virus infection: focusing on cell death and stress pathways in influenza virus replication. Iran J Allergy Asthma Immunol. 2013;12(1):1-17.
60. Naik SR, Panda VS. Antioxidant and hepatoprotective effects of Ginkgo biloba phytosomes in carbon tetrachloride-induced liver injury in rodents. Liver Int. 2007;27(3):393-9.
61. Vardi N, Parlakpinar H, Ozturk F, Ates B, Gul M, Cetin A, et al. Potent protective effect of apricot and β-carotene on methotrexate-induced intestinal oxidative damage in rats. Food Chem Toxicol. 2008;46(9):3015-22.
62. Uraz S, Tahan V, Aygun C, Eren F, Unluguzel G, Yuksel M, et al. Role of ursodeoxycholic acid in prevention of methotrexate-induced liver toxicity. Dig Dis Sci. 2008;53(4):1071-7.
63. Apel K, Hirt H. Reactive oxygen species: metabolism, oxidative stress, and signal transduction. Annu Rev Plant Biol. 2004;55:373-99.
64. Jahovic N, Cevik H, Sehirli AO, Yegen BC, Sener G. Melatonin prevents methotrexate-induced hepatorenal oxidative injury in rats. J Pineal Res. 2003;34(4):282-7.
65. Cetinkaya A, Bulbuloglu E, Kurutas EB, Kantarceken B. N-acetylcysteine ameliorates methotrexate-induced oxidative liver damage in rats. Med Sci Monit. 2006;12(8):BR274-278.
66. Jahovic N, Sener G, Cevik H, Ersoy Y, Arbak S, Yegen BC. Amelioration of methotrexate-induced enteritis by melatonin in rats. Cell Biochem Funct. 2004;22(3):169-78.
67. Babiak RM, Campello AP, Carnieri EG, Oliveira MB. Methotrexate: pentose cycle and oxidative stress. Cell Biochem Funct. 1998;16(4):283-93.
68. Fiocchi C. Inflammatory bowel disease: new insights into mechanisms of inflammation and increasingly customized approaches to diagnosis and therapy. Curr Opin Gastroenterol. 2004;20(4):309-10.
69. Los M, Khazaie K, Schulze-Osthoff K, Baeuerle PA, Schirrmacher V, Chlichlia K. Human T cell leukemia virus-I (HTLV-I) Tax-mediated apoptosis in activated T cells requires an enhanced intracellular prooxidant state. J Immunol (Baltimore, Md: 1950). 1998;161(6):3050-5.
70. Walker TM, Rhodes PC, Westmoreland C. The differential cytotoxicity of methotrexate in rat hepatocyte monolayer and spheroid cultures. Toxicol In Vitro. 2000;14(5):475-85.
71. Rouse K, Nwokedi E, Woodliff JE, Epstein J, Klimberg VS. Glutamine enhances selectivity of chemotherapy through changes in glutathione metabolism. Ann Surg. 1995;221(4):420-6.
72. Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem. 2005;38(12):1103-11.
73. Balasubramanian T, Senthilkumar G, Karthikeyan M, Chatterjee T. Protective Effect of Ethyl Acetate Fraction of Stereospermum Suaveolens Against Hepatic Oxidative Stress in STZ Diabetic Rats. J Tradit Complement Med. 2013;3(3):175.
74. Rezaei-Moghadam A, Mohajeri D, Rafiei B, Dizaji R, Azhdari A, Yeganehzad M, et al. Effect of turmeric and carrot seed extracts on serum liver biomarkers and hepatic lipid peroxidation, antioxidant enzymes and total antioxidant status in rats. BioImpacts: BI. 2012;2(3):151.
75. Somchit MN, Sulaiman M, Noratunlina R, Ahmad Z. Hepatoprotective effects of Curcuma longa rhizomes in paracetamol-induced liver damage in rats. In: Proceedings of the Regional Symposium on Environment and Natural Resources:. 2002;2002:698-702.
76. Fu Y, Zheng S, Lin J, Ryerse J, Chen A. Curcumin protects the rat liver from CCl4-caused injury and fibrogenesis by attenuating oxidative stress and suppressing inflammation. Mol Pharmacol. 2008;73(2):399-409.
77. Ramaiah SK. A toxicologist guide to the diagnostic interpretation of hepatic biochemical parameters. Food Chem Toxicol. 2007;45(9):1551-7.
78. Shakoori A, Butt U, Riffat R, Aziz F. Haematological and Biochemical Effects of Danitol Admin stered for two Months in the Blood and Liver of Rabbits. ZEITSCHRIFT FUR ANGEWANDTE ZOOLOGIE. 1994;80:165-80.
79. Navarro MC, Montilla MP, Martín A, Jiménez J, Utrilla MP. Free radical scavenger and antihepatotoxic activity of Rosmarinus tomentosus. Planta Med. 1993;59(04):312-4.
80. Te Helen S, Schiano TD, Kuan SF, Hanauer SB, Conjeevaram HS, Baker AL. Hepatic effects of long-term methotrexate use in the treatment of inflammatory bowel disease. Am J Gastroenterol. 2000;95(11):3150-6.
81. Liju VB, Jeena K, Kuttan R. Acute and subchronic toxicity as well as mutagenic evaluation of essential oil from turmeric (Curcuma longa L). Food Chem Toxicol. 2013;53:52-61.
82. Kim SW, Ha KC, Choi EK, Jung SY, Kim MG, Kwon DY, et al. The effectiveness of fermented turmeric powder in subjects with elevated alanine transaminase levels: a randomised controlled study. BMC Complement Altern Med. 2013;13:58.
83. Cieslar-Pobuda A, Back M, Magnusson K, Jain MV, Rafat M, Ghavami S, et al. Cell type related differences in staining with pentameric thiophene derivatives. Cytometry A. 2014;85(7):628-35.
84. Cieslar-Pobuda A, Wiechec E. Research on liver regeneration as an answer to the shortage of donors for liver transplantation. Hepatol Res. 2014;44(9):944-6.
85. Rollano Penaloza OM, Lewandowska M, Stetefeld J, Ossysek K, Madej M, Bereta J, et al. Apoptins: selective anticancer agents. Trends Mol Med. 2014;20(9):519-28.
86. Wasik AM, Grabarek J, Pantovic A, Cieslar-Pobuda A, Asgari HR, Bundgaard-Nielsen C, et al. Reprogramming and carcinogenesis--parallels and distinctions. Int Rev Cell Mol Biol. 2014;308:167-203.
87. Wiechec E. Implications of genomic instability in the diagnosis and treatment of breast cancer. Expert Rev Mol Diagn. 2011;11(4):445-53.
88. Yeganeh B, Hashemi M, de Serres FJ, Los MJ, Ghavami S. Different faces of hepatocellular carcinoma as a health threat in 21st century. Hepat Mon. 2013;13(2), e9308.
89. Yeganeh B, Wiechec E, Ande SR, Sharma P, Moghadam AR, Post M, et al. Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease. Pharmacol Ther. 2014;143(1):87-110.